The involvement of CCL17 in modulating the progression of diseases such as idiopathic pulmonary fibrosis has been reported, but its role in the pathogenesis of CKD remains to be elucidated. The gene discussed is CCL17; the disease is idiopathic pulmonary fibrosis.